Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
YM-201636
Cat. No.:
OB0225LY-0424
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
YM-201636 is a small molecule compound that primarily targets the mTOR signaling pathway and has profound effects on cell proliferation and metabolism.
Synonym:
371942-69-7; YM201636; YM 201636; 6-Amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide; 3-Pyridinecarboxamide, 6-amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-
CAS No.:
371942-69-7
Compound CID:
9956222
Formula:
C25H21N7O3
Formula Weight:
467.48
Specification
Relative Density:
1.446 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
YM-201636 can be used to study cell growth and metabolism-related diseases and to explore the role of mTOR in cell biology.
Library Information
Targets:
Kinases
Receptors:
p110α; PIKfyve
Pathways:
Autophagy; PI3K/Akt/mTOR signaling; Microbiology/Virology
Plate Number:
AOCL-6
Plate Location:
d10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
13.33 mg/mL; 28.52 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
ALogP:
2.467
HBA_Count:
7
HBD_Count:
2
Rotatable Bond:
4
